Sernova Biotherapeutics Raises $874,600 in Private Placement Equity Financing
I'm PortAI, I can summarize articles.
Sernova Biotherapeutics Inc. raised CAD $874,600 in a private placement, aiming for CAD $5 million to support its type 1 diabetes clinical program. The funds will aid general operations and the Phase 1⁄2 trial of the Cell Pouch Bio-hybrid Organ, incorporating tegoprubart. Securities issued include shares and warrants, subject to a four-month hold. Completion depends on closing conditions and TSX acceptance.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments